Home Tags Neurodegenerative Diseases

Neurodegenerative Diseases Related Content

ultrasounds psychiatric conditions, transcranial ultrasound stimulation

Could we treat psychiatric disorders with ultrasounds?

Research has found that low-intensity transcranial ultrasound stimulation can modulate brain activity and behaviours, supporting the observations of psychiatric conditions.
creatine deficiency, genetic treatment

Genetic disease treatment research for creatine deficiency

Professor Olivier Braissant, believes there is hope for the treatment of creatine deficiency thanks to new genetic disease research - here, he tells us all about the recent developments.
North America analysis

October 2021 North America Analysis

A very warm welcome to the Winter volume of North America Analysis: In our health & social care section, Dr Eduardo Bianco, Chair of the Tobacco Expert Group at the World Heart Federation discusses the ongoing battle to end the tobacco epidemic and how e-cigarettes may be part of the problem.
pain intensity, chronic pain

Scientists find that expectations influence pain intensity

The study found that expectations of how painful something will be, actually changes how the pain feels.
chronic pain, acute pain

Scientists find molecular reason for creation of chronic pain

A new study finds the exact molecular mechanism that turns acute pain into chronic pain - a condition that leads to the use of opioids and often, lifelong addiction.
brain creates motivation, receptors

Scientists reveal how the brain creates motivation

The study, published in PLoS Biology, looked at the neurotransmitter in the brain that calculates whether to pursue a task - in other words, motivation.
Latinx with dementia

Latinx with dementia: Culture matters

Dr Lynn Woods, Professor in the Department of Doctoral Programs, School of Nursing, Azusa Pacific University, describes Latinx with dementia and in this respect, why culture matters.
importance of psychedelic medicine

The impact and importance of psychedelic medicine

Here, we discover the impact and importance of psychedelic medicine through the eyes of Amanda Feilding, Director of The Beckley Foundation.
Patients and Public Involvement

Patient and Public Involvement at the heart of brain research

Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
living with Huntington's Disease

Supporting families living with Huntington’s Disease

Chief Executive of the Huntington’s Disease Association, Cath Stanley, maps out the charities ongoing work to support its community, despite the COVID-19 pandemic.
future of neuroscience

Investing in the future of neuroscience

Nina Schor, Deputy Director and Acting Scientific Director of NINDS, underlines the importance of investing in the future of neuroscience.
blood test dementia, psychiatric

Finnish scientists invent blood test for dementia

A new study by the University of Eastern Finland finds that a blood test could help to diagnose patients with frontotemporal dementia.
cure for neurological disorders, non-invasive method

Indiana team explores nanoparticle cure for neurological disorders

Indiana University School of Medicine researchers are attempting to use magnetic nanoparticles to develop a cure for neurological disorders from epilepsy to Alzheimer's - without any invasive or genetic treatment.
symptom tracking, biomarkers

Novel digital biomarkers to aid in the diagnosis and tracking of symptoms in patients...

Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.
alzheimer’s and parkinson’s diseases

JPND: Enabling collaborative research in Alzheimer’s and Parkinson’s diseases

Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
paths to dementia

Understanding the many possible paths to dementia

Dr Roderick Corriveau, PhD from the National Institute of Neurological Disorders & Stroke, part of the National Institutes of Health in the U.S., details the importance of understanding the many possible paths to dementia.
Department of Pathology and Cell Biology

Single Nuclei RNA Sequencing of Huntington’s Disease Brain Tissues

Doctors Osama Al Dalahmah and James E. Goldman discuss their work on single Nuclei RNA sequencing of Huntington’s disease brain tissues.
target of COVID-19, brain

The Brain: an unexpeted target of COVID-19

Here, Professor Pamela Lein at University of California, Davis, discusses the relatively unexplored issue of the human brain as a target of COVID-19.
huntington's disease research, cell biology

Huntington’s disease (HD) research

Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.
mild cognitive impairment

Identifying dementia & mild cognitive impairment

Dr Timothy Kwok, Professor at The Chinese University of Hong Kong, shares the development of the Electronic Cognitive Screen (EC-Screen) for population screening of dementia in older people.

Follow Open Access Government